To further investigate the molecular characteristics and the role of enlarged mast cells which are particularly prevalent in the tumor and TLN tissues of NAC-resistant patients, we identified the low expression of BTG2 as the predominant differential molecular feature in these cells (Figure 2A). The gene discussed is BTG2; the disease is neoplasm.